Previous 10 | Next 10 |
2024-03-08 11:20:00 ET Summary Olstein Capital Management follows an accounting-driven, value-oriented investing philosophy based on the premise that the price of a common stock may not reflect the true value of a company's underlying business. Both of our Funds, the Olstein All C...
2024-02-25 18:50:34 ET More on Enovis Corporation, Paragon 28, etc. Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript Enovis Corporation Non-GAAP EPS of $0.79 beats by $0.05, revenue of $455.02M beats by $9.63M Enovis Corporation Q4 2023 Earnings Preview ...
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2024 PR Newswire WARSAW, Ind. , Feb. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has app...
2024-02-13 00:39:21 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
Zimmer Biomet Signs Global Health Equity Network's Zero Health Gaps Pledge and Expands Longstanding Commitment to Advancing Health Equity PR Newswire -- Company's Recently Established Health Equity Division Leads Efforts to Address Disparities in Health Access and Outcomes -- ...
Zimmer Biomet Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting PR Newswire -- Booth Highlights Include Persona ® OsseoTi ® Keel Tibia, a Preview of ROSA ® Shoulder * , Pending 510(k) Clearance, and the HAMMR...
2024-02-09 13:30:02 ET Raymond James analyst issues UNDERPERFORM recommendation for ZBH on February 9, 2024 01:00PM ET. The previous analyst recommendation was Underperform. ZBH was trading at $121.57 at issue of the analyst recommendation. The overall analyst consensus ...
2024-02-09 13:30:02 ET RBC Capital analyst issues EQUAL-WEIGHT recommendation for ZBH on February 9, 2024 01:00PM ET. The previous analyst recommendation was Equal-Weight. ZBH was trading at $121.57 at issue of the analyst recommendation. The overall analyst consensus : ...
(NewsDirect) Orthobiologics represents a dynamic field within healthcare where the body's natural healing mechanisms address osteoarthritis and enhance recovery from tendon and ligament injuries. These therapies signify a significant evolution in medical treatment, offering promising solution...
2024-02-08 13:15:22 ET Zimmer Biomet Holdings, Inc. (ZBH) Q4 2023 Earnings Conference Call February 8, 2024, 8:30 am ET Company Participants Keri Mattox - Chief Communications & Administration Officer Ivan Tornos - President & CEO Suky Upadhyay - CFO &...
News, Short Squeeze, Breakout and More Instantly...
Zimmer Biomet Holdings Inc. Company Name:
ZBH Stock Symbol:
NYSE Market:
Zimmer Biomet Holdings Inc. Website:
2024-07-15 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results PR Newswire WARSAW, Ind. , July 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will ...
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors PR Newswire WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdika...